Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, October 22, 2026

Back to today

From X

@BrokenMoats 1 click

Broken Moats on X

$PEGA numbers begin the software back to earth story....expect sick to be down significantly tomorrow (it never trades true until the open). The backlog is down QoQ and we are talking 6% ACV now versus guide for 15% at the start of the year. Without a total break from recent trends they will need an absolute monstrous Q4 (comping against a very strong Q4 number yoy coming up) otherwise the backlog number will drop out and that will move from an inflated 15% yoy (from the Q4 25') probably to low single digits or worse..... Big portions of software is in trouble, this is the very beginning
@AsifSuria

Asif Suria on X

On the public company side, I have been looking into the boring company Mueller Water Products $MWA that makes things like fire hydrants. Yes, there is a data center angle but that part of their business is currently small. It showed up on my radar because of insider buying by an independent board member though a 10b5-1 plan. This director previously spent nearly 24 years at Morgan Stanley rising up to the position of Managing Director and Co-Head of Mergers & Acquisitions (Americas). Has an MBA from @UChicago and currently teaches at University of Virginia.

Investor Letters

All letters

Mosaic, Part One: The Story

Mosaic’s history traces the 2004 Cargill-IMC merger and the phosphate and potash mines that shaped NYSE: MOS.

MOS $5.5B
Latticework by MOI Global 15 clicks

Mosaic, Part Two: The Deep Dive

Mosaic, NYSE: MOS, is the subject of a second audio program for professional investors analyzing fertilizer producers.

MOS $5.5B
Latticework by MOI Global 4 clicks

Unicycive (UNCY):

Unicycive’s oxylanthanum carbonate NDA earned a March 25, 2027 PDUFA date after two manufacturing-related rejections, with no FDA clinical…

UNCY $110M
Triple S Special Situations Investing 4 clicks
UNCY · long

Unicycive Therapeutics INC

Unicycive Therapeutics fell nearly 50% after a second FDA Complete Response Letter tied to a third-party manufacturer for its primary…

UNCY $110M
Value Investors Club

GLOO, part two

Gloo faces related-party deals, insider-heavy IPO ownership, acquisition losses and $84.5 million of CEO-backed puts as it burns cash and…

GLOO $291M
Guardian Research 4 clicks

Why I sold OB pick for 26 SVM

Silvercorp’s falling Ying grades, prolonged GC suspension, El Domo execution risk and Chaarat funding needs weaken its valuation despite…

SVM $2B
The Oak Bloke 27 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 54 of 247

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

90 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.